Status:
COMPLETED
Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Hodgkin's Disease
Lymphoma
Eligibility:
All Genders
18-100 years
Brief Summary
Background: * Researchers are greatly interested in knowing more about the long-term effects of various treatments for cancers such as Hodgkin's disease, particularly from those who have lived 20 to ...
Detailed Description
BACKGROUND: Nearly 75% of Hodgkin's Disease (HD) patients can be cured of their disease with chemotherapy and radiotherapy, resulting in a growing number of long-term survivors. Adverse effects of H...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Inclusion Criteria for all Participants:
- Patients must be at least 18 years of age 15
- Patients must have been previously treated for Hodgkin's Disease at the NIH
- Patient must be willing to complete quality of life questionnaires and to answer questions regarding their medical history
- Patient must be willing to provide release of medical information forms for physicians and hospitals involved in their management
- Inclusion Criteria for Evaluation at NIH/NIA:
- In addition to those above,
- Patient is willing to return to NIH/NIA to participate in the protocol
- Patient must have a primary physician in the community who is willing to communicate with NIH regarding clinical findings and collaborate in the clinical management and follow-up of the patient. This will be substantiated by communicating directly with the patient's physician prior to evaluation.
- Pregnant patients are eligible for follow up evaluations and quality of life evaluations. They will be excluded for any radiological testing and invasive studies. Any blood draws will be approved by the patient's obstetrician and if any of the laboratory tests to be performed have been carried out within the last three months, those values will be used instead of repeating them. Alternatively, pregnant patients may choose to participate in the study after the birth of their child to be able to participate in the full evaluation.
- EXCLUSION CRITERIA:
- Inability to give informed consent
- Patients, and/ or guardians who are in the estimation of the PI, deemed unable or unlikely to adhere to protocol evaluations and follow-up requirements.
Exclusion
Key Trial Info
Start Date :
April 17 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 26 2010
Estimated Enrollment :
157 Patients enrolled
Trial Details
Trial ID
NCT00924131
Start Date
April 17 2009
End Date
May 26 2010
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892